-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Return On Equity history and growth rate from 2018 to 2024.
- Dianthus Therapeutics, Inc. /DE/ Return On Equity for the quarter ending March 31, 2024 was -30.5 %, a 139% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2023 was -74.2 %, a 184% decline from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2022 was 88.5 %.
- Dianthus Therapeutics, Inc. /DE/ annual Return On Equity for 2021 was -10.4 %, a 84.3% increase from 2020.
Return On Equity, Quarterly (% [USD])
Return On Equity, YoY Quarterly Growth (%)